Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| HIV Envelope Protein gp41 | 1 | 2019 | 153 | 0.70 | Why? |
| Epitope Mapping | 1 | 2019 | 1240 | 0.53 | Why? |
| HIV Antibodies | 1 | 2019 | 776 | 0.49 | Why? |
| Peptide Library | 1 | 2015 | 564 | 0.48 | Why? |
| Chemokines | 1 | 2015 | 1095 | 0.38 | Why? |
| Interferon Type I | 4 | 2021 | 2789 | 0.34 | Why? |
| Epitopes | 1 | 2019 | 4113 | 0.32 | Why? |
| Autoantibodies | 3 | 2021 | 2094 | 0.29 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.23 | Why? |
| IgA Deficiency | 2 | 2018 | 36 | 0.23 | Why? |
| CD8 Antigens | 1 | 2021 | 72 | 0.23 | Why? |
| Receptors, CXCR3 | 1 | 2021 | 159 | 0.22 | Why? |
| Antibodies, Neutralizing | 5 | 2021 | 25288 | 0.20 | Why? |
| Immunoglobulin A, Secretory | 1 | 2018 | 56 | 0.19 | Why? |
| Loss of Function Mutation | 1 | 2020 | 244 | 0.18 | Why? |
| Interferon beta-1a | 1 | 2021 | 316 | 0.17 | Why? |
| B7-H1 Antigen | 1 | 2021 | 541 | 0.17 | Why? |
| Plasmapheresis | 1 | 2021 | 437 | 0.17 | Why? |
| CX3C Chemokine Receptor 1 | 1 | 2015 | 21 | 0.16 | Why? |
| Bacteriophages | 1 | 2019 | 268 | 0.15 | Why? |
| Receptors, Chemokine | 1 | 2015 | 56 | 0.15 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.15 | Why? |
| Immunoglobulin A | 3 | 2021 | 3567 | 0.14 | Why? |
| Latent Tuberculosis | 1 | 2018 | 324 | 0.14 | Why? |
| Receptors, CCR5 | 1 | 2015 | 186 | 0.13 | Why? |
| Plasma Exchange | 1 | 2021 | 763 | 0.13 | Why? |
| Molecular Biology | 1 | 2015 | 139 | 0.13 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.12 | Why? |
| CD4-Positive T-Lymphocytes | 2 | 2021 | 4545 | 0.12 | Why? |
| Chemokine CCL20 | 1 | 2010 | 47 | 0.11 | Why? |
| beta-Defensins | 1 | 2010 | 38 | 0.11 | Why? |
| Apoptosis | 2 | 2011 | 2335 | 0.10 | Why? |
| HIV-1 | 2 | 2019 | 3365 | 0.10 | Why? |
| Blood Flow Velocity | 1 | 2010 | 193 | 0.10 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.09 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.09 | Why? |
| Mice, Inbred BALB C | 1 | 2019 | 5814 | 0.09 | Why? |
| T-Lymphocytes, Helper-Inducer | 1 | 2010 | 497 | 0.08 | Why? |
| Peptides | 1 | 2019 | 2513 | 0.08 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.08 | Why? |
| Ritonavir | 1 | 2021 | 4212 | 0.08 | Why? |
| Interleukin-17 | 1 | 2010 | 602 | 0.08 | Why? |
| Protein Binding | 2 | 2021 | 11430 | 0.08 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.07 | Why? |
| Neutralization Tests | 1 | 2019 | 6698 | 0.07 | Why? |
| Models, Molecular | 1 | 2019 | 7616 | 0.07 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.07 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.06 | Why? |
| Molecular Docking Simulation | 1 | 2019 | 6902 | 0.06 | Why? |
| Immunoassay | 1 | 2018 | 4485 | 0.06 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 5002 | 0.06 | Why? |
| Mice | 2 | 2019 | 21357 | 0.05 | Why? |
| Interferon Regulatory Factor-7 | 1 | 2020 | 234 | 0.05 | Why? |
| Cell Line | 1 | 2015 | 12040 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2019 | 8041 | 0.05 | Why? |
| Endothelium, Vascular | 1 | 2010 | 1751 | 0.05 | Why? |
| Inflammation Mediators | 1 | 2010 | 2654 | 0.05 | Why? |
| Genetic Loci | 1 | 2020 | 439 | 0.05 | Why? |
| Receptor, Interferon alpha-beta | 1 | 2020 | 610 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.04 | Why? |
| Tuberculin Test | 1 | 2018 | 141 | 0.04 | Why? |
| Humans | 17 | 2021 | 930598 | 0.04 | Why? |
| Toll-Like Receptor 3 | 1 | 2020 | 391 | 0.04 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.04 | Why? |
| Lymphocyte Activation | 2 | 2021 | 2742 | 0.04 | Why? |
| Interferon-gamma Release Tests | 1 | 2018 | 253 | 0.04 | Why? |
| Adult | 7 | 2021 | 244371 | 0.04 | Why? |
| Common Variable Immunodeficiency | 1 | 2018 | 195 | 0.04 | Why? |
| Antibodies, Bacterial | 1 | 2018 | 510 | 0.04 | Why? |
| Paris | 1 | 2018 | 1287 | 0.03 | Why? |
| Alleles | 1 | 2020 | 1557 | 0.03 | Why? |
| Aged | 5 | 2021 | 215776 | 0.03 | Why? |
| Interferon-alpha | 1 | 2021 | 1442 | 0.03 | Why? |
| Animals | 3 | 2019 | 78931 | 0.03 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2021 | 3608 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2020 | 9091 | 0.03 | Why? |
| Male | 6 | 2021 | 367725 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 2309 | 0.03 | Why? |
| Female | 6 | 2021 | 380317 | 0.03 | Why? |
| Receptors, CCR6 | 1 | 2010 | 45 | 0.03 | Why? |
| Asymptomatic Infections | 2 | 2020 | 7218 | 0.03 | Why? |
| Epidermis | 1 | 2010 | 47 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2021 | 2262 | 0.03 | Why? |
| Keratinocytes | 1 | 2010 | 119 | 0.03 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Infant | 2 | 2021 | 30274 | 0.02 | Why? |
| Microbiota | 1 | 2018 | 1240 | 0.02 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.02 | Why? |
| Cell Movement | 1 | 2010 | 695 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Ligands | 1 | 2010 | 1300 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2020 | 4027 | 0.02 | Why? |
| HIV Infections | 1 | 2011 | 11620 | 0.02 | Why? |
| Interleukins | 1 | 2010 | 762 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| France | 1 | 2021 | 12074 | 0.02 | Why? |
| Feces | 1 | 2018 | 4235 | 0.02 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.02 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 7868 | 0.02 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.01 | Why? |
| Cells, Cultured | 1 | 2010 | 5835 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.00 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.00 | Why? |
Dorgham's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(122)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(349)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_